What is the recommended dose of Acyclovir (antiviral medication) for a patient with herpes simplex virus (HSV) meningitis and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for HSV Meningitis

For adults with HSV meningitis and normal renal function, administer acyclovir 10 mg/kg intravenously every 8 hours for 14-21 days. 1, 2

Standard Dosing Protocol

  • The dose is 10 mg/kg IV every 8 hours (total daily dose of 30 mg/kg/day) for adults with confirmed or suspected HSV meningitis 1, 2, 3
  • Each dose should be infused over 1 hour to minimize nephrotoxicity 4
  • Treatment duration should be 14-21 days to ensure adequate viral suppression and prevent relapse 1, 3

Critical Distinction: Meningitis vs. Encephalitis

While the question asks about meningitis, it's essential to recognize that HSV encephalitis requires the same dose (10 mg/kg IV every 8 hours) but represents a more severe condition with altered mental status and parenchymal brain involvement 1, 2. The dosing is identical, but the clinical urgency differs—encephalitis has mortality rates of 70% without treatment versus 20-30% with acyclovir 5.

Treatment Initiation and Monitoring

  • Start acyclovir within 6 hours of admission if HSV CNS infection is suspected, even before CSF PCR confirmation, as early treatment (within 4 days of symptom onset) reduces mortality to 8% compared to 28% with delayed treatment 1, 2
  • CSF PCR remains positive for 7-10 days after starting treatment, so delayed lumbar puncture can still confirm diagnosis 5
  • Consider repeat CSF PCR at 14-21 days in patients without appropriate clinical response; if still positive, continue antiviral therapy 1, 2

Hydration and Nephrotoxicity Prevention

  • Maintain adequate hydration throughout treatment as acyclovir can cause crystalluria and obstructive nephropathy in up to 20% of patients, typically manifesting after 4 days of IV therapy 5, 1
  • Monitor serum creatinine regularly during treatment 1, 4
  • The drug is 62-91% renally excreted, making renal function monitoring mandatory 4

Common Pitfalls to Avoid

  • Never use oral acyclovir for acute HSV meningitis—IV therapy is mandatory for CNS infections as oral formulations do not achieve adequate CSF levels 5
  • Do not use fixed doses; always calculate based on actual body weight at 10 mg/kg 2
  • Do not stop treatment prematurely—the original 10-day regimens led to relapse rates of 26-29% in children, which is why current guidelines recommend 14-21 days 5

Renal Dose Adjustments

For patients with impaired renal function, dose adjustments are mandatory 1, 4:

  • Creatinine clearance >50 mL/min: Standard dose (10 mg/kg every 8 hours)
  • Creatinine clearance 25-50 mL/min: 10 mg/kg every 12 hours
  • Creatinine clearance 10-25 mL/min: 10 mg/kg every 24 hours
  • Hemodialysis patients: 5 mg/kg after each dialysis session 4

Special Populations

Immunocompromised Patients

  • May require prolonged courses beyond 21 days if CSF PCR remains positive 5, 1
  • If acyclovir resistance is suspected (persistent symptoms despite therapy), consider foscarnet 40 mg/kg IV every 8 hours as alternative 5, 6

Pediatric Dosing

  • Children 3 months to 12 years: 500 mg/m² IV every 8 hours (equivalent to approximately 20 mg/kg/day) 1, 7
  • Neonates with HSV CNS disease: 20 mg/kg IV every 8 hours for 21 days (higher dose due to worse outcomes in this age group) 5, 2
  • Adolescents >12 years: Adult dosing of 10 mg/kg IV every 8 hours 1

Relapse Considerations

  • Relapse rates can reach 5% even after appropriate treatment, particularly in children aged 3 months-12 years (up to 29%) 5, 1
  • Patients with recurrent HSV-2 meningitis may benefit from suppressive therapy with oral valacyclovir after the acute episode, though optimal duration is not well-established 8

References

Guideline

Acyclovir Dosing for HSV Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acyclovir Dosing Guidelines for Herpes Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.